<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EPR Biotech News</title>
	<atom:link href="https://eprbiotechnews.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://eprbiotechnews.com</link>
	<description></description>
	<lastBuildDate>Wed, 29 Oct 2025 14:05:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>BioNet Achieves EU-GMP Certification for its Pertussis Vaccine</title>
		<link>https://eprbiotechnews.com/2025/10/29/bionet-achieves-eu-gmp-certification-for-its-pertussis-vaccine/</link>
					<comments>https://eprbiotechnews.com/2025/10/29/bionet-achieves-eu-gmp-certification-for-its-pertussis-vaccine/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Wed, 29 Oct 2025 14:05:03 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Regulations]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[acellular pertussis vaccine]]></category>
		<category><![CDATA[BioNet]]></category>
		<category><![CDATA[certification]]></category>
		<category><![CDATA[compliance]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=315</guid>

					<description><![CDATA[LYON, 29-Oct-2025 — /EuropaWire/ —&#160;BioNet&#160;today announced it has received European Union Good Manufacturing Practice (EU-GMP) certification, an internationally recognized benchmark of pharmaceutical quality and compliance, to produce its acellular pertussis vaccine. “This milestone underscores BioNet’s resolute dedication to world-class manufacturing standards and marks a key step in the ongoing centralized regulatory review of its recombinant [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2025/10/29/bionet-achieves-eu-gmp-certification-for-its-pertussis-vaccine/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Myeloid Therapeutics rebrands and unveils an expanded strategy to move beyond its previous myeloid cell focus</title>
		<link>https://eprbiotechnews.com/2025/10/08/myeloid-therapeutics-rebrands-and-unveils-an-expanded-strategy-to-move-beyond-its-previous-myeloid-cell-focus/</link>
					<comments>https://eprbiotechnews.com/2025/10/08/myeloid-therapeutics-rebrands-and-unveils-an-expanded-strategy-to-move-beyond-its-previous-myeloid-cell-focus/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Tue, 07 Oct 2025 21:50:55 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[RNA]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[CREATE Medicines]]></category>
		<category><![CDATA[Daniel Getts]]></category>
		<category><![CDATA[myeloid cells]]></category>
		<category><![CDATA[Myeloid Therapeutics]]></category>
		<category><![CDATA[NK cells]]></category>
		<category><![CDATA[T cells]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=309</guid>

					<description><![CDATA[CAMBRIDGE, MA, 8-Oct-2025 — /EuropaWire/ — CREATE Medicines, Inc. (formerly Myeloid Therapeutics, Inc.) today announced an expanded strategy to move beyond myeloid-focused in vivo programming toward multilineage immune programming, including T cells, myeloid cells, and NK cells, to deliver scalable, redosable, off-the-shelf therapies with greater clinical impact. CREATE is the most advanced&#160;clinical-stage company in RNA-based in vivo CAR therapeutics, with [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2025/10/08/myeloid-therapeutics-rebrands-and-unveils-an-expanded-strategy-to-move-beyond-its-previous-myeloid-cell-focus/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Brain-Computer Interface Market Expands: IDTechEx Report Reveals Rising Competitors and Innovations Beyond Neuralink</title>
		<link>https://eprbiotechnews.com/2024/09/25/brain-computer-interface-market-expands-idtechex-report-reveals-rising-competitors-and-innovations-beyond-neuralink/</link>
					<comments>https://eprbiotechnews.com/2024/09/25/brain-computer-interface-market-expands-idtechex-report-reveals-rising-competitors-and-innovations-beyond-neuralink/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Wed, 25 Sep 2024 14:59:32 +0000</pubDate>
				<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Science]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=303</guid>

					<description><![CDATA[CAMBRIDGE, 25-Sep-2024 — /EuropaWire/ — In recent years, brain-computer interface (BCI) technologies have garnered widespread attention with the promise of revolutionizing how humans interact with machines—potentially replacing traditional interfaces like touch screens and mice, and offering breakthroughs in areas like speech decoding, wheelchair control, and even driving cars. Although much of the public focus has [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2024/09/25/brain-computer-interface-market-expands-idtechex-report-reveals-rising-competitors-and-innovations-beyond-neuralink/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Austrianova and San Raffaele University &#038; Research Hospital initiate a Joint Development Programme to prevent the progression of multiple myeloma</title>
		<link>https://eprbiotechnews.com/2023/05/19/austrianova-and-san-raffaele-university-research-hospital-initiate-a-joint-development-programme-to-prevent-the-progression-of-multiple-myeloma/</link>
					<comments>https://eprbiotechnews.com/2023/05/19/austrianova-and-san-raffaele-university-research-hospital-initiate-a-joint-development-programme-to-prevent-the-progression-of-multiple-myeloma/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Fri, 19 May 2023 19:06:10 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Acid protection]]></category>
		<category><![CDATA[bioencapsulation]]></category>
		<category><![CDATA[microbiome]]></category>
		<category><![CDATA[Microbiota]]></category>
		<category><![CDATA[microencapsulation]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[probiotic bacteria]]></category>
		<category><![CDATA[Probiotics]]></category>
		<category><![CDATA[shelf-life]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=297</guid>

					<description><![CDATA[SINGAPORE, 19-May-2023 â€” /EPR BIOTECH NEWS/ â€” Multiple myeloma is an incurable neoplasia of plasma cells causing anaemia, hypercalcemia, renal insufficiency, and bone lesions. This is due to malignant&#160;plasma cells accumulating in&#160;bone marrow&#160;â€” the soft, spongy&#160;tissue&#160;at the centre of bones â€” crowding out the normal plasma cells that help fight infection. Multiple myeloma usually presents [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2023/05/19/austrianova-and-san-raffaele-university-research-hospital-initiate-a-joint-development-programme-to-prevent-the-progression-of-multiple-myeloma/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>XSpline Cloud, first-in-class cloud platform for personalized cardiac resynchronization therapy, evaluated in International Clinical Trial</title>
		<link>https://eprbiotechnews.com/2023/03/20/xspline-cloud-first-in-class-cloud-platform-for-personalized-cardiac-resynchronization-therapy-evaluated-in-international-clinical-trial/</link>
					<comments>https://eprbiotechnews.com/2023/03/20/xspline-cloud-first-in-class-cloud-platform-for-personalized-cardiac-resynchronization-therapy-evaluated-in-international-clinical-trial/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 20 Mar 2023 17:40:19 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=293</guid>

					<description><![CDATA[BOLZANO/ BOZEN, Italy, 19-Mar-2023 â€” /EPR BIOTECH NEWS/ â€”Â XSpline SPA, a start-up company incorporated in Bolzano (Italy) and the Ordensklinikum Linz Elisabethinen Hospital in Linz (Austria) today announced the first patient enrolled in a clinical study (ClinicalTrials.govID: NCT05327062) for the cardiac resynchronization therapy (CRT) guided by non-invasive electrical and venous anatomy assessment. Â The international multicenter [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2023/03/20/xspline-cloud-first-in-class-cloud-platform-for-personalized-cardiac-resynchronization-therapy-evaluated-in-international-clinical-trial/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Austrianova Secures Significant Investment from Real Tech Fund</title>
		<link>https://eprbiotechnews.com/2021/07/07/austrianova-secures-significant-investment-from-real-tech-fund/</link>
					<comments>https://eprbiotechnews.com/2021/07/07/austrianova-secures-significant-investment-from-real-tech-fund/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Wed, 07 Jul 2021 14:43:00 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Acid protection]]></category>
		<category><![CDATA[Cellulose sulphate]]></category>
		<category><![CDATA[Encapsulation]]></category>
		<category><![CDATA[Gut microbiome dysbiosis]]></category>
		<category><![CDATA[Living cell encapsulation]]></category>
		<category><![CDATA[Microbiota]]></category>
		<category><![CDATA[Probiotics]]></category>
		<guid isPermaLink="false">https://eprbiotechnews.com/?p=287</guid>

					<description><![CDATA[&#160; SINGAPORE,Â 2021-Jul-7 â€” /EPR BIOTECH NEWS/ â€”Â Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased and honoured to announce that, after extensive due diligence, Real Tech Fund (managed by Real Tech Holdings, Japan) has invested an undisclosed seven figure amount in Austrianova via its Real Tech Global Fund 1 to accelerate Austrianovaâ€™s [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2021/07/07/austrianova-secures-significant-investment-from-real-tech-fund/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Clinical trial started to verify whether the use of a nasals spray preparation containing azelastine can help fight COVID-19</title>
		<link>https://eprbiotechnews.com/2021/02/18/clinical-trial-started-to-verify-whether-the-use-of-a-nasals-spray-preparation-containing-azelastine-can-help-fight-covid-19/</link>
					<comments>https://eprbiotechnews.com/2021/02/18/clinical-trial-started-to-verify-whether-the-use-of-a-nasals-spray-preparation-containing-azelastine-can-help-fight-covid-19/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Thu, 18 Feb 2021 08:11:27 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[anti-allergic medication Pollival]]></category>
		<category><![CDATA[anti-COVID therapeutics]]></category>
		<category><![CDATA[antihistamine drug]]></category>
		<category><![CDATA[antiviral properties]]></category>
		<category><![CDATA[azelastine]]></category>
		<category><![CDATA[azelastine hydrochloride]]></category>
		<category><![CDATA[CEBINA GmbH]]></category>
		<category><![CDATA[Central European Biotech Incubator and Accelerator]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[COVID-19 medication]]></category>
		<category><![CDATA[Covid-19 pandemic]]></category>
		<category><![CDATA[COVID-19 treatment]]></category>
		<category><![CDATA[nasal spray]]></category>
		<category><![CDATA[NASAL SPRAY COVID-19]]></category>
		<category><![CDATA[ophthalmology]]></category>
		<category><![CDATA[Pollival]]></category>
		<category><![CDATA[Prof Dr Robert Konrat]]></category>
		<category><![CDATA[Prof Dr. Ferenc Jakab]]></category>
		<category><![CDATA[re-purpose drugs]]></category>
		<category><![CDATA[SARS-CoV-2]]></category>
		<category><![CDATA[Sophie Zettl]]></category>
		<category><![CDATA[University of PÃ©cs]]></category>
		<category><![CDATA[University of Vienna]]></category>
		<category><![CDATA[URSAPHARM Arzneimittel GmbH]]></category>
		<category><![CDATA[viral spread COVID-19]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=283</guid>

					<description><![CDATA[SAARBRÃœCKEN / VIENNA, 17-Feb-2021 â€” /EPR BIOTECH NEWS/ â€” In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around the world are focusing on identifying new anti-COVID therapeutics that includes re-evaluation of existing [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2021/02/18/clinical-trial-started-to-verify-whether-the-use-of-a-nasals-spray-preparation-containing-azelastine-can-help-fight-covid-19/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Complete protection of probiotics from destruction by stomach acid using Bac-in-a-Box technology</title>
		<link>https://eprbiotechnews.com/2020/11/30/complete-protection-of-probiotics-from-destruction-by-stomach-acid-using-bac-in-a-box-technology/</link>
					<comments>https://eprbiotechnews.com/2020/11/30/complete-protection-of-probiotics-from-destruction-by-stomach-acid-using-bac-in-a-box-technology/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 30 Nov 2020 14:19:00 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Genome]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Acid protection]]></category>
		<category><![CDATA[Austrianova]]></category>
		<category><![CDATA[Bac-in-a-Box]]></category>
		<category><![CDATA[Brian Salmons]]></category>
		<category><![CDATA[Cell-in-a-Box]]></category>
		<category><![CDATA[Cellulose sulphate]]></category>
		<category><![CDATA[Encapsulation]]></category>
		<category><![CDATA[Gut microbiome dysbiosis]]></category>
		<category><![CDATA[Living cell encapsulation]]></category>
		<category><![CDATA[Microbiota]]></category>
		<category><![CDATA[Probiotics]]></category>
		<category><![CDATA[Prof. Walter H. Gunzburg]]></category>
		<category><![CDATA[SG Austria Group]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=278</guid>

					<description><![CDATA[SINGAPORE,Â 2020-Nov-30 â€” /EPR BIOTECH NEWS/ â€” Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-BoxÂ®, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal â€œMicrobial Cell Factoriesâ€ https://rdcu.be/cbn0O. Stomach acid is natureâ€™s way of ensuring that any microbes in [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2020/11/30/complete-protection-of-probiotics-from-destruction-by-stomach-acid-using-bac-in-a-box-technology/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Combined Shigella and ETEC vaccine candidate enters Phase 1 clinical study with radically innovative approach</title>
		<link>https://eprbiotechnews.com/2020/09/25/combined-shigella-and-etec-vaccine-candidate-enters-phase-1-clinical-study-with-radically-innovative-approach/</link>
					<comments>https://eprbiotechnews.com/2020/09/25/combined-shigella-and-etec-vaccine-candidate-enters-phase-1-clinical-study-with-radically-innovative-approach/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Fri, 25 Sep 2020 07:44:06 +0000</pubDate>
				<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[CEBINA]]></category>
		<category><![CDATA[Central European Biotech Incubator and Accelerator]]></category>
		<category><![CDATA[clinical testing]]></category>
		<category><![CDATA[Clinical Trail]]></category>
		<category><![CDATA[Diarrhea]]></category>
		<category><![CDATA[Diarrhoeal]]></category>
		<category><![CDATA[Diarrhoeal diseases]]></category>
		<category><![CDATA[Enterotoxigenic E. coli]]></category>
		<category><![CDATA[ETEC]]></category>
		<category><![CDATA[European Vaccine Initiative]]></category>
		<category><![CDATA[Eveliqure]]></category>
		<category><![CDATA[Eveliqure Biotechnologies]]></category>
		<category><![CDATA[Eveliqure Biotechnologies GmbH]]></category>
		<category><![CDATA[Frank Malinoski]]></category>
		<category><![CDATA[GÃ¡bor Somogyi]]></category>
		<category><![CDATA[Horizon 2020]]></category>
		<category><![CDATA[icddr b]]></category>
		<category><![CDATA[PATH]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[Pharma & Biotech]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Shigella]]></category>
		<category><![CDATA[ShigETEC]]></category>
		<category><![CDATA[SHIGETECVAX]]></category>
		<category><![CDATA[Travel Diarrhea]]></category>
		<category><![CDATA[University of Gothenburg]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[vaccine candidate]]></category>
		<category><![CDATA[Wellcome Trust Healthcare]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=274</guid>

					<description><![CDATA[VIENNA, 24-Sep-2020 â€” /EPR BIOTECH NEWS/ â€”Â Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity study in Europe. ShigETEC is an orally administered vaccine candidate targeting Shigella and Enterotoxigenic E. coli [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2020/09/25/combined-shigella-and-etec-vaccine-candidate-enters-phase-1-clinical-study-with-radically-innovative-approach/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes</title>
		<link>https://eprbiotechnews.com/2020/05/22/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes/</link>
					<comments>https://eprbiotechnews.com/2020/05/22/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Fri, 22 May 2020 14:28:34 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA["cell encapsulation"]]></category>
		<category><![CDATA[Austrianova]]></category>
		<category><![CDATA[bioproduction]]></category>
		<category><![CDATA[Brian Salmons]]></category>
		<category><![CDATA[Cells for Cells]]></category>
		<category><![CDATA[exosomes]]></category>
		<category><![CDATA[Maroun Khoury]]></category>
		<category><![CDATA[mesenchymal stem cells (MSCs)]]></category>
		<category><![CDATA[regenerative diseases]]></category>
		<category><![CDATA[stem cell therapy]]></category>
		<category><![CDATA[Stem cells]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=267</guid>

					<description><![CDATA[SINGAPORE,Â 2020-May-22 â€” /EPR BIOTECH NEWS/ â€”Â Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs). These EVs are known to mediate many of the therapeutic effects of stem cells. The authors [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2020/05/22/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CoapTech and Fidmi Medical to Collaborate on Groundbreaking G-Tube Systems</title>
		<link>https://eprbiotechnews.com/2019/09/18/coaptech-and-fidmi-medical-to-collaborate-on-groundbreaking-g-tube-systems/</link>
					<comments>https://eprbiotechnews.com/2019/09/18/coaptech-and-fidmi-medical-to-collaborate-on-groundbreaking-g-tube-systems/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Wed, 18 Sep 2019 18:01:54 +0000</pubDate>
				<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[bedside care]]></category>
		<category><![CDATA[CoapTech]]></category>
		<category><![CDATA[Dr. Steven Tropello]]></category>
		<category><![CDATA[Fidmi Medical]]></category>
		<category><![CDATA[gastroenterologists]]></category>
		<category><![CDATA[Gastrostomy]]></category>
		<category><![CDATA[Lloyd Fishman]]></category>
		<category><![CDATA[point of care]]></category>
		<category><![CDATA[PUMA-G System]]></category>
		<category><![CDATA[ultrasound]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=262</guid>

					<description><![CDATA[Baltimore, MD, 2019-Sep-18 â€” /EPR BIOTECH NEWS/ â€”Â CoapTechÂ LLC (Baltimore, MD) andÂ Fidmi Medical, Ltd. (Caesarea, Israel) announced today that they will be collaborating on bringing to market a set of next-generation products for the initial placement and long-term maintenance of gastrostomy tubes (G-tubes). The collaboration between CoapTech and Fidmi will focus on integrating the companyâ€™s two [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2019/09/18/coaptech-and-fidmi-medical-to-collaborate-on-groundbreaking-g-tube-systems/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Mr RICHARD GUILLAUME IS APPOINTED TO THE DIAFIR BOARD OF DIRECTORS</title>
		<link>https://eprbiotechnews.com/2019/04/08/mr-richard-guillaume-is-appointed-to-the-diafir-board-of-directors/</link>
					<comments>https://eprbiotechnews.com/2019/04/08/mr-richard-guillaume-is-appointed-to-the-diafir-board-of-directors/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 08 Apr 2019 11:12:21 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Board Diafir]]></category>
		<category><![CDATA[diagnostic]]></category>
		<category><![CDATA[in vitro diagnostic tests]]></category>
		<category><![CDATA[medical technology company]]></category>
		<category><![CDATA[NASH]]></category>
		<category><![CDATA[nonalcoholic steatohepatitis]]></category>
		<category><![CDATA[Richard Guillaume]]></category>
		<category><![CDATA[septic arthritis]]></category>
		<category><![CDATA[steatohepatitis technology]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=258</guid>

					<description><![CDATA[RENNES, FRANCE, 2019-Apr-08 â€” /EPR BIOTECH NEWS/ â€”Â DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions in nonalcoholic steatohepatitis (NASH) and septic arthritis announces today the appointment of Mr Richard Guillaume to its Board of Directors Mr Guillaume has a wide experience of over 30 years in international [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2019/04/08/mr-richard-guillaume-is-appointed-to-the-diafir-board-of-directors/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Global leader in flexible containment solutions ILC Dover expands its Irish production footprint by opening a location in Blarney, County Cork, Ireland</title>
		<link>https://eprbiotechnews.com/2018/11/02/global-leader-in-flexible-containment-solutions-ilc-dover-expands-its-irish-production-footprint-by-opening-a-location-in-blarney-county-cork-ireland/</link>
					<comments>https://eprbiotechnews.com/2018/11/02/global-leader-in-flexible-containment-solutions-ilc-dover-expands-its-irish-production-footprint-by-opening-a-location-in-blarney-county-cork-ireland/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Fri, 02 Nov 2018 07:12:17 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[aerospace]]></category>
		<category><![CDATA[biopharma]]></category>
		<category><![CDATA[Blarney]]></category>
		<category><![CDATA[Brendan Lucey]]></category>
		<category><![CDATA[containment solutions]]></category>
		<category><![CDATA[County Cork]]></category>
		<category><![CDATA[Curtis Gingles]]></category>
		<category><![CDATA[expansion]]></category>
		<category><![CDATA[flexible containment solutions]]></category>
		<category><![CDATA[flood]]></category>
		<category><![CDATA[Fran DiNuzzo]]></category>
		<category><![CDATA[ILC Dover]]></category>
		<category><![CDATA[Ireland]]></category>
		<category><![CDATA[packaging]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[powder handling solutions]]></category>
		<category><![CDATA[powder handling solutions biopharma]]></category>
		<category><![CDATA[safety]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=254</guid>

					<description><![CDATA[FREDERICA, DE, USA, 01-Nov-2018 â€” /EPR BIOTECH NEWS/ â€”Â ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry is expanding its Irish production footprint by opening a location in Blarney, County Cork, Ireland. The building will be operational in the first quarter of 2019 and outfitted with 4,000 square feet [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2018/11/02/global-leader-in-flexible-containment-solutions-ilc-dover-expands-its-irish-production-footprint-by-opening-a-location-in-blarney-county-cork-ireland/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Asian Study Confirms Favorable Results of Fotona SMOOTHÂ® Laser Therapy for Urinary Incontinence</title>
		<link>https://eprbiotechnews.com/2018/09/24/asian-study-confirms-favorable-results-of-fotona-smooth-laser-therapy-for-urinary-incontinence/</link>
					<comments>https://eprbiotechnews.com/2018/09/24/asian-study-confirms-favorable-results-of-fotona-smooth-laser-therapy-for-urinary-incontinence/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 24 Sep 2018 14:04:31 +0000</pubDate>
				<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[aesthetics]]></category>
		<category><![CDATA[bladder]]></category>
		<category><![CDATA[Chang Gung Memorial Hospital]]></category>
		<category><![CDATA[Chang-Hua Hospital]]></category>
		<category><![CDATA[clinical paper]]></category>
		<category><![CDATA[dentistry]]></category>
		<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Dr. Adolf Lukanovic]]></category>
		<category><![CDATA[Dr. Mija Blaganje]]></category>
		<category><![CDATA[Dr. Nobuo Okui]]></category>
		<category><![CDATA[Dr. Yi-Hao Lin]]></category>
		<category><![CDATA[Dr. Yi-Wen Tien]]></category>
		<category><![CDATA[dual-tissue regeneration]]></category>
		<category><![CDATA[Dynamis XS]]></category>
		<category><![CDATA[Er:YAG laser therapy]]></category>
		<category><![CDATA[erbiumâ€‘doped yttrium aluminum garnet laser therapy]]></category>
		<category><![CDATA[Fotona]]></category>
		<category><![CDATA[Fotona d.o.o.]]></category>
		<category><![CDATA[Fotona SMOOTHÂ® Er:YAG laser thermotherapy]]></category>
		<category><![CDATA[Fotona SMOOTHÂ® laser technology]]></category>
		<category><![CDATA[Fotona SMOOTHÂ® technology]]></category>
		<category><![CDATA[genitourinary syndrome of menopause]]></category>
		<category><![CDATA[gynecological treatment options]]></category>
		<category><![CDATA[gynecologists]]></category>
		<category><![CDATA[gynecology]]></category>
		<category><![CDATA[ICIQ-SF]]></category>
		<category><![CDATA[IncontiLaseÂ®]]></category>
		<category><![CDATA[IncontiLaseÂ® Er:YAG]]></category>
		<category><![CDATA[IncontiLaseÂ® Er:YAG laser therapy]]></category>
		<category><![CDATA[International Consultation on Incontinence Questionnaire Short Form]]></category>
		<category><![CDATA[laser]]></category>
		<category><![CDATA[laser irradiation]]></category>
		<category><![CDATA[laser therapy]]></category>
		<category><![CDATA[medical lasers]]></category>
		<category><![CDATA[Non-ablative erbium yttrium aluminum garnet laser]]></category>
		<category><![CDATA[non-invasive treatment of SUI]]></category>
		<category><![CDATA[One-hour pad test]]></category>
		<category><![CDATA[overactive bladder]]></category>
		<category><![CDATA[Overactive bladder symptom score]]></category>
		<category><![CDATA[patient safety]]></category>
		<category><![CDATA[pelvic organ prolapse]]></category>
		<category><![CDATA[premenopausal parous women]]></category>
		<category><![CDATA[ProlapLaseÂ®]]></category>
		<category><![CDATA[RenovaLaseÂ®]]></category>
		<category><![CDATA[stress]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[SUI symptoms]]></category>
		<category><![CDATA[superficial heat-shocking mechanism]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[surgical sling procedures]]></category>
		<category><![CDATA[Tension-free vaginal tape]]></category>
		<category><![CDATA[tension-free vaginal tape - TVT]]></category>
		<category><![CDATA[thermotherapy]]></category>
		<category><![CDATA[tissue regeneration]]></category>
		<category><![CDATA[TOT procedures]]></category>
		<category><![CDATA[Transobturator tape]]></category>
		<category><![CDATA[transobturator tape - TOT]]></category>
		<category><![CDATA[TVT procedures]]></category>
		<category><![CDATA[urinary incontinence]]></category>
		<category><![CDATA[urodynamic stress incontinence]]></category>
		<category><![CDATA[vaginal collagen hyperthermia]]></category>
		<category><![CDATA[vaginal laxity â€“ vaginal relaxation syndrome]]></category>
		<category><![CDATA[vaginal tissues]]></category>
		<category><![CDATA[vaginal wall]]></category>
		<category><![CDATA[World Journal of Urology urinary incontinence]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=248</guid>

					<description><![CDATA[LJUBLJANA, Slovenia, 21-Sep-2018 â€” /EPR BIOTECH NEWS/ â€” The latest study published in the World Journal of Urology (Comparison between erbiumâ€‘doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence â€“Â https://doi.org/10.1007/s00345-018-2445-x) provides further confirmation that Fotona SMOOTHÂ® laser technology is a safe, effective and minimally-invasive solution for [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2018/09/24/asian-study-confirms-favorable-results-of-fotona-smooth-laser-therapy-for-urinary-incontinence/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>FINALLY, A REAL INNOVATION IN DENTAL CARE â€“ THE ONLY DUAL MODE LIGHT THERAPY ELECTRIC TOOTHBRUSH LAUNCHES ON KICKSTARTER</title>
		<link>https://eprbiotechnews.com/2018/03/26/finally-a-real-innovation-in-dental-care-the-only-dual-mode-light-therapy-electric-toothbrush-launches-on-kickstarter/</link>
					<comments>https://eprbiotechnews.com/2018/03/26/finally-a-real-innovation-in-dental-care-the-only-dual-mode-light-therapy-electric-toothbrush-launches-on-kickstarter/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 26 Mar 2018 07:53:10 +0000</pubDate>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[electric toothbrush]]></category>
		<category><![CDATA[gingivitis]]></category>
		<category><![CDATA[gum health]]></category>
		<category><![CDATA[light therapy]]></category>
		<category><![CDATA[oral care]]></category>
		<category><![CDATA[oral hygiene]]></category>
		<category><![CDATA[sonic vibration]]></category>
		<category><![CDATA[systematic disease]]></category>
		<category><![CDATA[teeth whitening]]></category>
		<category><![CDATA[toothbrush]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=241</guid>

					<description><![CDATA[Los Angeles, California, 2018-Mar-26 â€” /EPR BIOTECH NEWS/ â€”Â Bristl combines proven science of light therapy with sonic vibration to improve oral care. The company also offers a subscription service to replace brush heads, so having the best oral health is also convenient. Available on Kickstarter on Monday, March 26th at 9am (PST) The combination of [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2018/03/26/finally-a-real-innovation-in-dental-care-the-only-dual-mode-light-therapy-electric-toothbrush-launches-on-kickstarter/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>International Symposium on the Accessibility to High-Value Medicine, December 5-6, 2017 in London</title>
		<link>https://eprbiotechnews.com/2017/12/03/10630-international-symposium-on-the-accessibility-to-high-value-medicine-december-5-6-2017-in-london/</link>
					<comments>https://eprbiotechnews.com/2017/12/03/10630-international-symposium-on-the-accessibility-to-high-value-medicine-december-5-6-2017-in-london/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Sun, 03 Dec 2017 11:48:15 +0000</pubDate>
				<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Law]]></category>
		<category><![CDATA[Licenses]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Regulations]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Accessibility to High-Value Medicine]]></category>
		<category><![CDATA[analytica|LASER]]></category>
		<category><![CDATA[auto-immune diseases]]></category>
		<category><![CDATA[biopharmaceutical developers]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[drug policy]]></category>
		<category><![CDATA[high-cost medical therapies]]></category>
		<category><![CDATA[High-Value Medicine]]></category>
		<category><![CDATA[life-saving drugs]]></category>
		<category><![CDATA[London School of Hygiene and Tropical Medicine]]></category>
		<category><![CDATA[rare diseases]]></category>
		<guid isPermaLink="false">https://www.eprbiotechnews.com/?p=231</guid>

					<description><![CDATA[LONDON, Dec-3-2017 â€” /EuropaWire/ â€” On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations convene in London (UK) to address the mounting challenge of accessibility and patient access to high-value, high-cost medical therapies. The not-for-profit executive forum is organised by theÂ London School of Hygiene and Tropical MedicineÂ andÂ analytica&#124;LASER, a global [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2017/12/03/10630-international-symposium-on-the-accessibility-to-high-value-medicine-december-5-6-2017-in-london/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>S-ACQUISITION CORP COMMENCES TENDER OFFER OF ASTRA LOGICS, INC.</title>
		<link>https://eprbiotechnews.com/2017/05/02/s-acquisition-corp-commences-tender-offer-of-astra-logics-inc/</link>
					<comments>https://eprbiotechnews.com/2017/05/02/s-acquisition-corp-commences-tender-offer-of-astra-logics-inc/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Tue, 02 May 2017 19:43:20 +0000</pubDate>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Astra Logics]]></category>
		<category><![CDATA[S-Acquisition Corp]]></category>
		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=225</guid>

					<description><![CDATA[New York, 2017-May-02 â€” /EPR BIOTECH NEWS/ â€”Â S-Acquisition Corporation is today commencing its tender offer for all 10,000,000 shares of Second Round financing of Common Stock of Astra Logics Inc., Hong Kong, at a price of US$7.00 per share, payable in cash. The offer, which has been unanimously approved and recommended by Astra Logicâ€™s Board [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2017/05/02/s-acquisition-corp-commences-tender-offer-of-astra-logics-inc/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Study: New laser-based imaging technique can detect inflammation more accurately</title>
		<link>https://eprbiotechnews.com/2017/03/30/38961-study-new-laser-based-imaging-technique-can-detect-inflammation-more-accurately/</link>
					<comments>https://eprbiotechnews.com/2017/03/30/38961-study-new-laser-based-imaging-technique-can-detect-inflammation-more-accurately/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Thu, 30 Mar 2017 20:41:22 +0000</pubDate>
				<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotech Solutions]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Crohnâ€™s disease]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[inflammatory bowel diseases]]></category>
		<category><![CDATA[laser-based imaging]]></category>
		<category><![CDATA[laser-based imaging technique]]></category>
		<category><![CDATA[New England Journal of Medicine]]></category>
		<category><![CDATA[new imaging technique]]></category>
		<category><![CDATA[Ulcerative colitis]]></category>
		<category><![CDATA[University Hospital Erlangen]]></category>
		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=221</guid>

					<description><![CDATA[GERMANY, Mar-30-2017 â€” /EPR Biotech News/ â€” Ulcerative colitis and Crohnâ€™s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2017/03/30/38961-study-new-laser-based-imaging-technique-can-detect-inflammation-more-accurately/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Nu-Tek Bioscience Announces study comparing various Soy and Pea Peptones and Yeast extracts on Nov. 14, 2016</title>
		<link>https://eprbiotechnews.com/2016/11/14/nu-tek-bioscience-announces-study-comparing-various-soy-and-pea-peptones-and-yeast-extracts-on-nov-14-2016-389042/</link>
					<comments>https://eprbiotechnews.com/2016/11/14/nu-tek-bioscience-announces-study-comparing-various-soy-and-pea-peptones-and-yeast-extracts-on-nov-14-2016-389042/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Mon, 14 Nov 2016 11:10:18 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[Animal free Peptones]]></category>
		<category><![CDATA[Blending HPP]]></category>
		<category><![CDATA[cell growth]]></category>
		<category><![CDATA[E. Coli]]></category>
		<category><![CDATA[HPP]]></category>
		<category><![CDATA[Hydrolyzed Pea Protein]]></category>
		<category><![CDATA[Hydrolyzed Soy Protein]]></category>
		<category><![CDATA[Nu-Tek Bioscience]]></category>
		<category><![CDATA[Nu-Tek HSP]]></category>
		<category><![CDATA[Pea Peptones]]></category>
		<category><![CDATA[Peptones]]></category>
		<category><![CDATA[protein sources]]></category>
		<category><![CDATA[Soy]]></category>
		<category><![CDATA[Soy Peptones]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[University of St. Thomas]]></category>
		<category><![CDATA[Yeast extracts]]></category>
		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=216</guid>

					<description><![CDATA[Allergan and Animal free Peptones for the use in culture media Minnetonka, MN, 2016-Nov-14 â€” /EPR Biotech News/ â€” Today at Nu-Tek Bioscience announced the completion of an outside study comparing various protein sources on the enhancement of Cell growth using E. Coli. The study was completed by The University of St. Thomas. Nu-Tek HSP [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2016/11/14/nu-tek-bioscience-announces-study-comparing-various-soy-and-pea-peptones-and-yeast-extracts-on-nov-14-2016-389042/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases</title>
		<link>https://eprbiotechnews.com/2016/05/25/genqual-and-r-pharm-collaborate-to-deliver-predictive-diagnostics-for-novel-anti-il-6-antibody-for-autoimmune-diseases/</link>
					<comments>https://eprbiotechnews.com/2016/05/25/genqual-and-r-pharm-collaborate-to-deliver-predictive-diagnostics-for-novel-anti-il-6-antibody-for-autoimmune-diseases/#respond</comments>
		
		<dc:creator><![CDATA[EPR Biotech News]]></dc:creator>
		<pubDate>Wed, 25 May 2016 10:53:14 +0000</pubDate>
				<category><![CDATA[Biochemicals]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biotech Products]]></category>
		<category><![CDATA[Biotech Services]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Technologies]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[anti-IL-6 antibody]]></category>
		<category><![CDATA[autoimmune diseases]]></category>
		<category><![CDATA[GenQual]]></category>
		<category><![CDATA[Jonathan Mirich]]></category>
		<category><![CDATA[R-Pharm collaborate]]></category>
		<category><![CDATA[Vasily Ignatiev]]></category>
		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=211</guid>

					<description><![CDATA[Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 â€” /EPR Biotech News/ â€”Â R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases. The GenQual proprietary real-time PCR platform, when applied to the genes that are involved [&#8230;]]]></description>
		
					<wfw:commentRss>https://eprbiotechnews.com/2016/05/25/genqual-and-r-pharm-collaborate-to-deliver-predictive-diagnostics-for-novel-anti-il-6-antibody-for-autoimmune-diseases/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Memcached (Page is feed) 

Served from: eprbiotechnews.com @ 2026-04-03 21:57:58 by W3 Total Cache
-->